GOLS yields 8.20% · JNJ yields 2.13%● Live data
📍 GOLS pulled ahead of the other in Year 1
Combined, GOLS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GOLS + JNJ for your $10,000?
GOLS is actively managed and invests in equity securities of companies engaged in the live media, entertainment, and sports sectors. It may invest in foreign securities, including American Depositary Receipts, and companies of any market capitalization. Up to 10% of net assets may be allocated to option contracts. Live media includes television, radio, motion pictures, internet content, and advertising services. Sports-related activities encompass team ownership, sports-related real estate, athletic apparel, equipment, ticketing, and sports media. The investment approach seeks undervalued assets based on private market value, considering factors such as price, earnings, balance sheets, management quality, and catalysts like industry changes or regulatory shifts. Investments may be sold if they lose perceived value due to price targets, fundamental changes, or risk/reward adjustments. Equity securities are subject to market fluctuations which expose investors to certain risks.
Full GOLS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.